Aspirin and colorectal cancer
1997

Aspirin and Colorectal Cancer

Sample size: 3248 publication Evidence: moderate

Author Information

Author(s): C La Vecchia, E Negri, S Franceschi, E Conti, M Montella, A Giacosa, F Falci, A Decarli

Primary Institution: Istituto di Ricerche Farmacologiche 'Mario Negri'

Hypothesis

Does regular aspirin use reduce the risk of colorectal cancer?

Conclusion

The study suggests that regular aspirin use may decrease the risk of colorectal cancer.

Supporting Evidence

  • Regular aspirin use was reported by only 3.5% of cases and 4.1% of controls.
  • The multivariate odds ratio for colorectal cancer among regular aspirin users was 0.7.
  • The risk of colorectal cancer tended to decrease with increasing duration of aspirin use.
  • The association was somewhat stronger in women and individuals below age 60.

Takeaway

Taking aspirin might help lower the chances of getting colorectal cancer, which is a type of cancer in the intestines.

Methodology

A case-control study was conducted in Italy examining aspirin use among colorectal cancer patients and matched controls.

Potential Biases

Some control diagnostic categories may have been associated with increased NSAID use, but results were consistent across categories.

Limitations

The number of regular aspirin users was low, which may affect the statistical power of the study.

Participant Demographics

The study included 1357 colorectal cancer cases and 1891 controls, with a median age of 62 years for cases and 59 years for controls.

Statistical Information

P-Value

0.7

Confidence Interval

0.5-1.0

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication